Cerebrospinal fluid amyloid-β (Aβ) as an effect biomarker for brain Aβ lowering verified by quantitative preclinical analyses (Q45159397)
Jump to navigation
Jump to search
scientific article published on 4 May 2012
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Cerebrospinal fluid amyloid-β (Aβ) as an effect biomarker for brain Aβ lowering verified by quantitative preclinical analyses |
scientific article published on 4 May 2012 |
Statements
1 reference
Cerebrospinal fluid amyloid-β (Aβ) as an effect biomarker for brain Aβ lowering verified by quantitative preclinical analyses (English)
1 reference
Yasong Lu
1 reference
David Riddell
1 reference
Eva Hajos-Korcsok
1 reference
Kelly Bales
1 reference
Kathleen M Wood
1 reference
Charles E Nolan
1 reference
Ashley E Robshaw
1 reference
Liming Zhang
1 reference
Louis Leung
1 reference
Stacey L Becker
1 reference
Elaine Tseng
1 reference
Jason Barricklow
1 reference
Emily H Miller
1 reference
Sarah Osgood
1 reference
Brian T O'Neill
1 reference
Michael A Brodney
1 reference
Douglas S Johnson
1 reference
Martin Pettersson
1 reference
4 May 2012
1 reference
1 reference
Identifiers
1 reference